As of November 2024, Neurones has a market cap of $1.15B. This makes Neurones the world's 7238th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $1.19B | 0.57% |
2023 | $1.18B | 11.46% |
2022 | $1.06B | 3.29% |
2021 | $1.03B | 62.39% |
2020 | $631.34M | 13.59% |
2019 | $555.80M | 8.99% |
2018 | $509.93M | -34.38% |
2017 | $777.04M | 28.80% |
2016 | $603.29M | 28.73% |
2015 | $468.65M | 25.32% |
2014 | $373.95M | 10.09% |
2013 | $339.69M | 51.87% |
2012 | $223.67M | 13.56% |
2011 | $196.96M | 6.10% |
2010 | $185.63M | 13.53% |
2009 | $163.50M | 31.74% |
2008 | $124.11M | -25.81% |
2007 | $167.28M | 28.36% |
2006 | $130.32M | -13.90% |
2005 | $151.36M | 19.36% |
2004 | $126.81M | -2.89% |
2003 | $130.59M | 34.44% |
2002 | $97.13M | 1.41% |
2001 | $95.78M | -15.07% |
2000 | $112.78M | - |